Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Pediatr Hematol Oncol ; 45(2): e272-e278, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36730676

ABSTRACT

Ependymomas account for 10% of all malignant pediatric central nervous system tumors. Standard therapy includes maximal safe surgical resection, followed by focal radiation. Despite the aggressive therapy, progression-free survival is poor. Most ependymoma relapses occur locally at the original tumor site. Extraneural presentations of ependymoma are extremely rare, and no standard of care treatment exists. We present a single-institution case series of 3 patients who experienced extraneural relapses of supratentorial ependymoma and describe their treatment and outcome. These cases of extraneural relapse highlight the possible modes of extraneural spread, including hematogenous, lymphatic, and microscopic seeding through surgical drains and shunts. In addition, they illustrate the increase in histologic grade and mutational burden that may occur at the time of relapse. These cases illustrate the role of aggressive, individualized treatment interventions using a combination of surgery, radiation, and chemotherapy.


Subject(s)
Ependymoma , Neoplasm Recurrence, Local , Humans , Child , Ependymoma/pathology , Combined Modality Therapy
4.
J Pediatr Hematol Oncol ; 43(7): e979-e982, 2021 Oct 01.
Article in English | MEDLINE | ID: mdl-33448717

ABSTRACT

Neurofibromatosis type 1 (NF1)-associated primary intramedullary spinal cord ganglioglioma has only rarely been reported. Because of frequent nonresectability, they pose significant management challenges despite clinical indolence. This report describes a 4-year-old girl with NF1 who was found to have multiple discrete, infiltrative intramedullary cord masses, and biopsy demonstrated World Health Organization grade I ganglioglioma. Panel-based next-generation sequencing showed her previously identified germline NF1 mutation and a second somatic NF1 mutation. This represents the first report of multiple primary intramedullary gangliogliomas in a child with NF1 and demonstrates how biopsy with panel-based next-generation sequencing provides potential targets for MAPK/MEK/BRAF pathway inhibitor therapy.


Subject(s)
Ganglioglioma/pathology , Neurofibromatosis 1/complications , Spinal Cord/pathology , Child, Preschool , Female , Ganglioglioma/etiology , Humans , Prognosis
5.
J Pediatr Hematol Oncol ; 43(7): e987-e990, 2021 Oct 01.
Article in English | MEDLINE | ID: mdl-33093355

ABSTRACT

Treatment-related morbidity drives research to identify targetable lesions in children with cancer. Neurotrophic tropomyosin receptor kinase (NTRK) alterations occur in ~1% of pediatric solid tumors. Early phase pediatric trials involving the NTRK inhibitor treatment for progressive NTRK-mutated cancers show promising results. The authors describe the adjuvant maintenance larotrectinib treatment after definitive surgical resection in 2 toddlers with NTRK fusion-positive malignancies (ETV6-NTRK3 fusion-positive undifferentiated embryonal sarcoma of the kidney and NACC2-NTRK2 fusion-positive anaplastic astrocytoma). Both are alive, in remission, developing normally and tolerating larotrectinib 15 months later, thus extending the NTRK inhibitor therapeutic spectrum by describing the adjuvant maintenance larotrectinib treatment in children with NTRK fusion-positive cancers associated with high recurrences.


Subject(s)
Astrocytoma/drug therapy , Kidney Neoplasms/drug therapy , Maintenance Chemotherapy/methods , Oncogene Proteins, Fusion/genetics , Pyrazoles/therapeutic use , Pyrimidines/therapeutic use , Astrocytoma/genetics , Astrocytoma/pathology , Chemotherapy, Adjuvant , Child, Preschool , Female , Humans , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Male , Membrane Glycoproteins/genetics , Neoplasm Proteins/genetics , Neoplasms, Germ Cell and Embryonal/drug therapy , Neoplasms, Germ Cell and Embryonal/genetics , Neoplasms, Germ Cell and Embryonal/pathology , Prognosis , Receptor, trkB/genetics , Repressor Proteins/genetics
6.
Stroke ; 49(4): 1011-1014, 2018 04.
Article in English | MEDLINE | ID: mdl-29540605

ABSTRACT

BACKGROUND AND PURPOSE: Quantitative arterial tortuosity (QAT) is a ratio of vessel length between 2 points to the shortest linear distance between same points. QAT has been reported as an imaging biomarker of arteriopathy in pediatric arterial ischemic stroke (AIS) because of dissection and transient cerebral arteriopathy. We sought to determine whether QAT abnormalities are present in other subtypes of pediatric AIS. METHODS: Children with AIS-absent conventional biomarkers of arteriopathy and case-controls who underwent magnetic resonance angiography were classified by stroke mechanism. The primary study population consisted of cryptogenic AIS cases. AIS with bow hunter physiology and cardiogenic emboli were also evaluated. AIS because of nontraumatic dissection served as positive controls. Patients without vascular risk factors served as negative controls. Segmental QAT of cervicocerebral arteries were measured using automated image processing and differences between groups analyzed. RESULTS: In negative controls, QAT showed significant age-related variability for most arterial segments. Positive controls showed significantly increased QAT of the distal extracranial vertebral arteries (VAs) and decreased QAT of the intracranial VA relative to negative controls. Cryptogenic stroke and bow hunter physiology cases were similar to positive controls showing increased QAT of the distal extracranial VA and decreased QAT of the intracranial VA relative to negative controls. Cardioembolic stroke cases were similar to negative controls showing decreased QAT of the distal extracranial VA and increased QAT of the intracranial VA relative to positive controls. CONCLUSIONS: Pediatric cryptogenic stroke is frequently associated with cervicocerebral arteriopathies expressing altered QAT. QAT may be a diagnostic biomarker of arteriopathy in pediatric AIS.


Subject(s)
Arteries/diagnostic imaging , Brain Ischemia/diagnostic imaging , Cerebral Arterial Diseases/diagnostic imaging , Stroke/diagnostic imaging , Adolescent , Case-Control Studies , Child , Child, Preschool , Female , Humans , Infant , Magnetic Resonance Angiography , Male , Retrospective Studies , Risk Factors , Young Adult
7.
Pediatr Radiol ; 48(4): 602-608, 2018 04.
Article in English | MEDLINE | ID: mdl-29362841

ABSTRACT

BACKGROUND: Alagille syndrome is a pediatric multisystem disease with increased prevalence of cerebrovascular disease. The spectrum of cerebrovascular disease in Alagille syndrome includes cerebral aneurysms, moyamoya arteriopathy and dolichoectasia. The prevalence of cerebrovascular disease in Alagille syndrome varies widely in the literature. OBJECTIVE: To determine the prevalence of cerebrovascular disease in our institution's Alagille patient population by employing a full primary review of all available neuroimaging. MATERIALS AND METHODS: An institutional review board-approved retrospective review of all Alagille syndrome patients seen at a tertiary care children's hospital from January 2000 to January 2014 was performed. All neuroimaging studies were reviewed for arterial or venous abnormalities. The prevalence of arterial and venous abnormalities was calculated and clinical outcomes were determined. RESULTS: Fifty-two patients with Alagille syndrome ranging in age from 11 months to 27 years were studied. Nineteen (37%) had dedicated vascular neuroimaging. Six (32%) had cerebral arterial disease, 4 with dolichoectasia, 3 with aneurysm(s) and 2 with moyamoya arteriopathy. Three of the four patients with dolichoectasia had associated aneurysm(s). Venous anomalies were present in 4 (21%) patients. One patient with moyamoya arteriopathy underwent revascularization procedures. No deaths were attributable to cerebrovascular disease. CONCLUSION: Cerebral vasculopathy is an important feature of Alagille syndrome and includes dolichoectasia, cerebral aneurysms and moyamoya arteriopathy. The high prevalence identified in our study suggests noninvasive vascular neuroimaging screening should be performed in this patient population. In addition to cerebral arterial abnormalities, alterations of venous development may be a feature of Alagille syndrome.


Subject(s)
Alagille Syndrome/complications , Alagille Syndrome/diagnostic imaging , Cardiovascular Diseases/diagnostic imaging , Cardiovascular Diseases/etiology , Cerebral Arterial Diseases/diagnostic imaging , Cerebral Arterial Diseases/etiology , Neuroimaging/methods , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Prevalence , Retrospective Studies
9.
Pediatr Radiol ; 47(13): 1828-1838, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29149371

ABSTRACT

Venous-related brain injury is a common form of cerebrovascular injury in children and encompasses a diverse group of cerebrovascular diagnoses. The purpose of this pictorial essay is to introduce the relevant anatomy, pathophysiology and various imaging patterns of venous-related cerebral injury in children. Unifying concepts to better understand the effects of venous hypertension in the developing brain will be emphasized. These unifying concepts will provide the imaging professional with a conceptual framework to better understand and confidently identify imaging patterns of venous-related cerebral injury.


Subject(s)
Brain Injuries/diagnostic imaging , Cerebral Veins/diagnostic imaging , Cerebral Veins/injuries , Diagnostic Imaging , Vascular System Injuries/diagnostic imaging , Brain Injuries/physiopathology , Child , Humans , Vascular System Injuries/physiopathology
10.
J Pediatr ; 182: 283-289.e1, 2017 03.
Article in English | MEDLINE | ID: mdl-27989412

ABSTRACT

OBJECTIVE: To assess whether computed tomography (CT), magnetic resonance imaging (MRI), and neurosurgical evaluations altered the diagnosis or management of children diagnosed with benign macrocrania of infancy by ultrasonography (US). STUDY DESIGN: We queried our radiology database to identify patients diagnosed with benign macrocrania of infancy by US between 2006 and 2013. Medical records of those with follow-up CT/MRI were reviewed to determine clinical/neurologic status and whether or not CT/MRI imaging resulted in diagnosis of communicating hydrocephalus or required neurosurgical intervention. RESULTS: Patients with benign macrocrania of infancy (n = 466) were identified (mean age at diagnosis: 6.5 months). Eighty-four patients (18.0%) received subsequent head CT/MRI; of these, 10 patients had neurologic abnormalities before 2 years of age, of which 3 had significant findings on MRI (temporal lobe white matter changes, dysmorphic ventricles, thinned corpus callosum). One patient without neurologic abnormalities had nonspecific white matter signal abnormality (stable over 6 months) but no change in management. None required neurosurgical intervention. Another 9/84 patients had incidental findings including Chiari I (3), small subdural bleeds (2), arachnoid cyst (1), small cavernous malformation (1), frontal bone dermoid (1), and a linear parietal bone fracture after a fall (1). CONCLUSIONS: Children diagnosed with benign macrocrania of infancy on US without focal neurologic findings do not require subsequent brain CT/MRI or neurosurgical evaluation. Decreasing unnecessary imaging would decrease costs, minimize radiation and sedation exposures, and increase clinic availability of neurology and neurosurgery specialists.


Subject(s)
Hydrocephalus/diagnostic imaging , Magnetic Resonance Imaging/statistics & numerical data , Megalencephaly/diagnostic imaging , Megalencephaly/pathology , Neuroimaging/methods , Tomography, X-Ray Computed/statistics & numerical data , Analysis of Variance , Cephalometry/methods , Child, Preschool , Cohort Studies , Databases, Factual , Female , Follow-Up Studies , Humans , Hydrocephalus/surgery , Infant , Infant, Newborn , Male , Megalencephaly/surgery , Monitoring, Physiologic , Neurologic Examination/methods , Neurosurgical Procedures/methods , Prognosis , Retrospective Studies , Risk Assessment , Ultrasonography, Doppler/statistics & numerical data
11.
Pediatr Radiol ; 46(3): 394-406; quiz 391-3, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26795616

ABSTRACT

Developmental venous anomalies (DVAs) are the most common vascular malformation of the brain and are commonly identified on routine imaging of the brain. They are typically considered incidental findings, usually with no clinical significance. However the increasing identification of DVAs as a result of improved imaging technology has led to recognition of their association with a variety of abnormal imaging findings and clinically important conditions. This pictorial essay explores the suspected embryological origin, associated imaging features, and proposed pathophysiological mechanisms of DVAs in the pediatric population. This paper emphasizes newer physiological imaging data, which suggest that DVA drainage has less physiological flexibility than otherwise normal venous drainage development.


Subject(s)
Cerebral Veins/abnormalities , Cerebral Veins/diagnostic imaging , Magnetic Resonance Angiography/methods , Vascular Malformations/diagnostic imaging , Vascular Malformations/embryology , Cerebral Veins/embryology , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male
13.
Biol Blood Marrow Transplant ; 21(11): 2028-32, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26226408

ABSTRACT

Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome characterized by vision changes, altered mental status, and seizures, typically caused by an acute rise in blood pressure. PRES has been reported after hematopoietic stem cell transplantation (HSCT) in association with hypertension from calcineurin inhibitors and corticosteroids. The imaging evaluation of PRES after HSCT in children and young adults has not been well described. We performed a retrospective review of all HSCT recipients presenting to the intensive care unit with new neurologic symptoms. A neuroradiologist reviewed all radiologic images and compared computed tomography (CT) versus magnetic resonance imaging (MRI) findings indicative of diagnosis of PRES. Alternative imaging diagnoses explaining the patients' symptoms were also recorded. Fifty-four transplant recipients were admitted to the intensive care unit with new neurologic symptoms. Thirty-nine percent (21 of 54) of subjects had imaging findings consistent with PRES, 24% (13 of 54) had imaging findings consistent with an alternative diagnosis, 9% (5 of 54) had a nonspecific finding, and 28% (15 of 54) had no acute imaging findings. PRES was diagnosed at a median of 49 days (interquartile range, 29 to 94) after HSCT. The presenting symptom for the majority of patients with PRES was seizures (86%), whereas 14% presented with acute encephalopathy. Ninety-five percent of subjects diagnosed with PRES (20 of 21) underwent a head CT as their initial imaging evaluation. CT scan was diagnostic of PRES in 40% (8 of 20). Subsequently, 16 patients underwent brain MRI with 12 additional patients being diagnosed with PRES on MRI. The median time elapsed between negative CT and a positive MRI examination was 20 hours (range, 3.6 hours to 9 days). CT serves as an excellent screening test for acute pathology, such as intracranial hemorrhage; however, it lacks sensitivity for the diagnosis of PRES. Patients with clinical symptoms suggestive of PRES who have a negative CT should be treated appropriately for PRES and should undergo MRI of the brain as soon as clinically stable to confirm the diagnosis.


Subject(s)
Hematopoietic Stem Cell Transplantation , Hypertension/diagnosis , Myeloablative Agonists/therapeutic use , Posterior Leukoencephalopathy Syndrome/diagnosis , Transplantation Conditioning , Adolescent , Anemia, Aplastic , Blood Pressure , Bone Marrow Diseases , Bone Marrow Failure Disorders , Child , Child, Preschool , Female , Graft vs Host Disease/immunology , Graft vs Host Disease/mortality , Graft vs Host Disease/pathology , Graft vs Host Disease/therapy , Hematologic Neoplasms/immunology , Hematologic Neoplasms/mortality , Hematologic Neoplasms/pathology , Hematologic Neoplasms/therapy , Hemoglobinuria, Paroxysmal/immunology , Hemoglobinuria, Paroxysmal/mortality , Hemoglobinuria, Paroxysmal/pathology , Hemoglobinuria, Paroxysmal/therapy , Humans , Hypertension/diagnostic imaging , Hypertension/mortality , Hypertension/therapy , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/mortality , Immunologic Deficiency Syndromes/pathology , Immunologic Deficiency Syndromes/therapy , Intensive Care Units , Magnetic Resonance Imaging , Male , Posterior Leukoencephalopathy Syndrome/diagnostic imaging , Posterior Leukoencephalopathy Syndrome/mortality , Posterior Leukoencephalopathy Syndrome/therapy , Retrospective Studies , Survival Analysis , Tissue Donors , Tomography, X-Ray Computed , Transplantation, Homologous
14.
Am J Hum Genet ; 96(5): 765-74, 2015 May 07.
Article in English | MEDLINE | ID: mdl-25913037

ABSTRACT

We report three individuals with a cranioskeletal malformation syndrome that we define as acrofacial dysostosis, Cincinnati type. Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1. All three individuals exhibit varying degrees of mandibulofacial dysostosis, and two additionally have limb anomalies. Consistent with this observation, we discovered that polr1a mutant zebrafish exhibited cranioskeletal anomalies mimicking the human phenotype. polr1a loss of function led to perturbed ribosome biogenesis and p53-dependent cell death, resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies. Our findings expand the genotypic and phenotypic heterogeneity of congenital acrofacial disorders caused by disruption of ribosome biogenesis.


Subject(s)
Limb Deformities, Congenital/genetics , Mandibulofacial Dysostosis/genetics , RNA Polymerase I/genetics , Ribosomes/genetics , Animals , Cell Death/genetics , Genotype , Humans , Limb Deformities, Congenital/physiopathology , Mandibulofacial Dysostosis/physiopathology , Mutation , Neural Crest/growth & development , Neural Crest/pathology , Ribosomes/pathology , Zebrafish
16.
Int J Pediatr Otorhinolaryngol ; 77(7): 1219-21, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23684166

ABSTRACT

Tolosa-Hunt syndrome is an idiopathic chronic granulomatous inflammatory process commonly involving the cavernous sinus and the orbit. Symptoms include unilateral eye pain, ophthalmoplegia, headache, and facial pain in the distribution of the upper divisions of the trigeminal nerve and are highly responsive to steroid therapy. Gradenigo syndrome describes extension of a middle ear infection to the petrous apex, with trigeminal pain and ophthalmoplegia, typically responsive to antibiotics and often surgical drainage. We report a case of a 17 year-old girl with apparent Gradenigo syndrome, presenting with unilateral eye pain, abducens palsy, headache, hearing loss and serous otitis media, who was ultimately diagnosed with Tolosa-Hunt syndrome.


Subject(s)
Cavernous Sinus/pathology , Ophthalmoplegia/diagnosis , Otitis Media/diagnosis , Petrositis/diagnosis , Tolosa-Hunt Syndrome/diagnosis , Adolescent , Diagnosis, Differential , Female , Humans , Ophthalmoplegia/etiology , Otitis Media/etiology
17.
Semin Intervent Radiol ; 28(4): 407-14, 2011 Dec.
Article in English | MEDLINE | ID: mdl-23204639

ABSTRACT

Interventional radiologists are playing an increasingly important role in pediatric urologic intervention, working closely with the pediatric urologist. Interventional radiologists are frequently asked to establish percutaneous access to the renal collecting system prior to nephrolithotomy. Additionally, procedures such as percutaneous nephrostomy, ureteral stent placement and exchange, and renal parenchymal biopsy are frequently encountered requests. This article will review these common procedures and highlight techniques and pathology that are unique to the pediatric population.

SELECTION OF CITATIONS
SEARCH DETAIL
...